How to Treat Thyroid Cancer

Order online in 2 minutes, visit a local lab same day, and get results in 1-3 days. No doctor's order needed.

No Doctor Required 4,500+ Lab Locations Results in 1-3 Days
Find a Lab Near Me

Thyroid cancer treatment today is highly individualized and typically involves a combination of surgery, radioactive iodine therapy, hormone suppression, and for advanced cases, targeted molecular therapies or immunotherapy. The approach depends on the cancer type (papillary, follicular, medullary, or anaplastic), stage, genetic markers, and patient health. This guide explains the standard protocols and emerging options available in the United States, helping you understand what to expect and how to monitor your thyroid health proactively.

Surgery: The Primary Treatment for Most Thyroid Cancers

Surgical removal of the thyroid gland (thyroidectomy) is the cornerstone of treatment for nearly all thyroid cancers. Today, minimally invasive techniques are standard, reducing recovery time and scarring.

Total Thyroidectomy vs. Lobectomy

  • Total thyroidectomy: removal of the entire thyroid gland. Recommended for tumors larger than 1–1.5 cm, bilateral nodules, or high-risk histology (e.g., tall cell variant, medullary cancer).
  • Lobectomy: removal of one lobe. Suitable for small, low-risk papillary or follicular cancers confined to one lobe. This preserves some thyroid function and may avoid lifelong hormone replacement.
  • Lymph node dissection: central compartment neck dissection is often performed if suspicious nodes are detected on ultrasound or during surgery.

Radioactive Iodine Therapy (RAI) After Surgery

RAI is used to ablate any remaining thyroid tissue or microscopic cancer cells after total thyroidectomy. It is effective only for iodine-avid cancers (papillary and follicular). Today, dosing is more precise using dosimetry and stimulated thyroglobulin levels. Patients must follow a low-iodine diet for 1–2 weeks before treatment.

Thyroid Hormone Suppression Therapy

After thyroidectomy, patients take levothyroxine (Synthroid) to replace thyroid hormone and suppress TSH (thyroid-stimulating hormone). A low TSH level reduces the risk of cancer recurrence because TSH can stimulate growth of remaining cancer cells. Dosage is adjusted based on TSH, thyroglobulin, and anti-thyroglobulin antibody levels.

Targeted Therapy and Immunotherapy for Advanced Disease

For metastatic or radioactive iodine-refractory thyroid cancers, precision medicine has advanced significantly. Today, the following targeted drugs are commonly used:

Drug ClassExamplesTarget
Tyrosine kinase inhibitors (TKIs)Lenvatinib, Sorafenib, CabozantinibVEGFR, RET, MET
BRAF/MEK inhibitorsDabrafenib + TrametinibBRAF V600E mutation
RET inhibitorsSelpercatinib, PralsetinibRET fusion/mutation
Checkpoint inhibitorsPembrolizumab (in trials)PD-1

Genetic testing of the tumor (via biopsy or surgical specimen) is now standard to identify actionable mutations. For example, RET-positive medullary thyroid cancer responds well to selpercatinib, while BRAF-mutated papillary cancers may benefit from combination BRAF/MEK inhibition.

External Beam Radiation Therapy (EBRT) and Chemotherapy

EBRT is reserved for unresectable local recurrences or bone metastases that cause pain or risk fracture. Chemotherapy (e.g., doxorubicin) is rarely used today, except for anaplastic thyroid cancer, where it may be combined with checkpoint inhibitors in clinical trials.

Monitoring and Follow-Up After Treatment

Long-term surveillance is critical. Today, standard follow-up includes:

  • Serum thyroglobulin and anti-thyroglobulin antibody measurements every 6–12 months.
  • Neck ultrasound annually for at least 5 years.
  • Whole-body iodine scans if RAI was used (less common now due to high sensitivity of thyroglobulin).
  • CT, PET/CT, or MRI for suspected metastatic disease.

Lifestyle and Supportive Care

Patients often experience fatigue, weight changes, and voice changes after surgery. Working with an endocrinologist, a speech therapist (for vocal cord function), and a dietitian can improve quality of life. Calcium and vitamin D supplements are needed if parathyroid glands are damaged during surgery.

If you have a family history of thyroid cancer, a personal history of radiation exposure to the neck, or symptoms like a lump in the neck, hoarseness, or difficulty swallowing, early detection is key. Order our comprehensive thyroid cancer monitoring panel today to track your thyroglobulin, TSH, and anti-thyroglobulin antibodies from the comfort of your home. Early intervention saves lives.

Ready to order your test?

Order online in 2 minutes and visit a local lab same day.

Find a Lab Near Me

Frequently asked questions

What is the first treatment for thyroid cancer?

Surgery (thyroidectomy) is the first-line treatment for most thyroid cancers. The extent depends on tumor size, type, and spread.

Do all thyroid cancer patients need radioactive iodine?

No. RAI is only used after total thyroidectomy for iodine-avid cancers (papillary and follicular) that are at intermediate or high risk of recurrence.

Can thyroid cancer be cured?

Yes, most differentiated thyroid cancers (papillary and follicular) have a 5-year survival rate over 98% when caught early and treated appropriately.

What targeted therapies are available for advanced thyroid cancer today?

TKIs like lenvatinib, BRAF/MEK inhibitors for BRAF-mutant tumors, and RET inhibitors like selpercatinib for RET-altered cancers.

Medical disclaimer: This guide is for general education only and is not medical advice. Test preparation and reference ranges vary by laboratory. Always follow instructions from your ordering provider and consult a qualified healthcare professional about your results.

Affiliate disclosure: MyLabPanel may earn a commission when you book a test through links on this page, at no extra cost to you.

Related resources